Rachel Johnson, PA
Physician Assistant · Woodbury, MNNPI 1720602485
Payments from drug & device makers
Across 73 payments — averaging $34.87 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medtronic$2K
- Olympus America Inc.$141
- Coloplast$116
- Boston Scientific$109
- Johnson & Johnson$93
- Convatec Inc.$76
- plus $438 from 18 others
Across 1 payment — averaging $210.00 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Medtronic$210
What the payments were for
- Travel & lodging$1,02940%
- Food & beverage$1,51660%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medtronic | 26 | $1,572 |
| Olympus America Inc. | 2 | $141 |
| Coloplast | 6 | $116 |
| Boston Scientific | 1 | $109 |
| Johnson & Johnson | 6 | $93 |
| Convatec Inc. | 4 | $76 |
| 180 Medical, Inc. | 4 | $61 |
| Teleflex LLC | 3 | $47 |
| Bayer | 2 | $40 |
| Sun Pharmaceutical Industries Inc. | 2 | $31 |
| Sumitomo Pharma America, Inc. | 2 | $30 |
| Astellas Pharma US Inc | 2 | $30 |
| Antares Pharma, Inc. | 2 | $28 |
| C. R. Bard, Inc. & Subsidiaries | 1 | $24 |
| Hollister Incorporated | 1 | $18 |
| Urogen Pharma, Inc. | 1 | $17 |
| Amgen | 1 | $15 |
| ABC Home Medical Supply, Inc. | 1 | $15 |
| Photocure Inc | 1 | $14 |
| Pfizer | 1 | $14 |
| Urovant Sciences Inc | 1 | $14 |
| Progenics Pharmaceuticals, Inc. | 1 | $14 |
| AstraZeneca | 1 | $14 |
| Dendreon Pharmaceuticals LLC | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- INTERSTIM$839
- iTIND System$127
- rezum Generator$109
How this compares
$2,546 in reported general payments places this provider in the 95th percentile of 3,121 physician assistant providers in Minnesota.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| GemtesaVibegron | 379 | $339,303 |
| MyrbetriqMirabegron | 305 | $239,807 |
| Estradiol | 337 | $21,262 |
| Trospium Chloride ErTrospium Chloride | 77 | $19,671 |
| Mirabegron ErMirabegron | 23 | $14,499 |
| ElmironPentosan Polysulfate Sodium | 12 | $10,033 |
| Tolterodine Tartrate ErTolterodine Tartrate | 102 | $8,167 |
| Solifenacin Succinate | 95 | $6,148 |
| Oxybutynin Chloride ErOxybutynin Chloride | 224 | $5,322 |
| Trospium Chloride | 53 | $3,329 |
| Methenamine Hippurate | 16 | $1,864 |
| Nitrofurantoin Mono-MacroNitrofurantoin Monohyd/M-Cryst | 109 | $1,254 |
| Cephalexin | 136 | $1,220 |
| NitrofurantoinNitrofurantoin Macrocrystal | 25 | $1,075 |
| Darifenacin ErDarifenacin Hydrobromide | 11 | $936 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Sumitomo Pharma America, Inc.Gemtesa | $30 | $339,303379 claims |
| Astellas Pharma US IncMyrbetriq | $30 | $239,807305 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 3,121 physician assistant providers in Minnesota.
Other physician assistant in Woodbury
- Kenneth MitchellWoodbury$87K
- Jeffrey SandquistWoodbury$26K
- Michael JensonWoodbury$7K
- Mitchell MacbethWoodbury$5K
- Sara RobeckBloomington$274K
- Natalie IkemanEdina$170K
- Adam HetzBlaine$156K
- Sarah SchettleRochester$150K
- John IsenbergMaple Grove$92K
- Jennifer SutherlandMinneapolis$65K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.